Boehm, Ilka http://orcid.org/0000-0001-9576-5396
Mohr, Holger
King, Joseph A. http://orcid.org/0000-0002-2864-5578
Steding, Julius http://orcid.org/0000-0002-4558-0323
Geisler, Daniel http://orcid.org/0000-0003-2076-5329
Wronski, Marie-Louis
Weigel, Katharina
Roessner, Veit http://orcid.org/0000-0002-1873-7081
Ruge, Hannes http://orcid.org/0000-0001-9793-3859
Ehrlich, Stefan http://orcid.org/0000-0003-2132-4445
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EH 367/5 - 1, EH 367/7 - 1, SFB 940)
Article History
Received: 4 March 2021
Revised: 18 August 2021
Accepted: 14 September 2021
First Online: 16 October 2021
Competing interests
: In the last 2 years, VR has received lecture fees from Eli Lilly, Janssen-Cilag, Medice, Novartis and was a member of advisory boards of Eli Lilly, Novartis. The remaining authors declare no competing interests.